Med-Tech Innovation February 23, 2024

Zimmer Biomet has received U.S. Food and Drug Administration (FDA) 510(k) clearance of the ROSA Shoulder System for robotic-assisted shoulder replacement surgery.

Zimmer says ROSA Shoulder is the world’s first robotic surgery system for shoulder replacement, and the fourth application for its ROSA Robotics portfolio, which includes the ROSA Knee System for total knee arthroplasty and ROSA Hip System for total hip replacement.

ROSA Shoulder strengthens Zimmer Biomet’s shoulder implant portfolio, which includes the Identity Shoulder System, and joins ZBEdge Dynamic Intelligence.

Ivan Tornos, president and chief executive officer at Zimmer Biomet, said: “We are proud and excited to be the first company in the world to deliver a robotic surgical assistant for anatomic and reverse shoulder replacement surgery. ROSA...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Medical Devices, Robotics/RPA, Technology
Only 20% of AI devices for children used pediatric data to train: 3 notes
Medtech firms have cut thousands of jobs this year. Will layoffs continue in 2025?
Proton therapy market in the US projected to reach $2.67 billion by 2033
How Trump’s second term will affect the medtech industry
Cala Health Snags $50M for At-Home Tremor Relief Therapy

Share This Article